Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Journal of Pharmacological and Toxicological Methods|April 15, 2017
Cardiac voltage-gated ion channels in safety pharmacology: Review of the landscape leading to the CiPA initiativeHai Huang, Michael K Pugsley, Bernard Fermini, et al.Prehospital and Disaster Medicine|February 14, 2014
A sustainable training strategy for improving health care following a catastrophic radiological or nuclear incidentDaniel J Blumenthal, Judith L Bader, Doran Christensen, et al.British Journal of Pharmacology|June 3, 2015
Evaluation of drug-induced QT interval prolongation in animal and human studies: a literature review of concordanceHugo M Vargas, Alan S Bass, John Koerner, et al.British Journal of Pharmacology|November 29, 2017
Can non-clinical repolarization assays predict the results of clinical thorough QT studies? Results from a research consortiumEunjung Park, Gary A Gintant, Daoqin Bi, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|February 11, 2022
The Challenges of Predicting Drug-Induced QTc Prolongation in HumansJean-Pierre Valentin, Peter Hoffmann, Catherine Ortemann-Renon, et al.Journal of Pharmacological and Toxicological Methods|April 10, 2013
A public-private consortium advances cardiac safety evaluation: achievements of the HESI Cardiac Safety Technical CommitteeJennifer B Pierson, Brian R Berridge, Marjory B Brooks, et al.Clinical Spine Surgery|July 19, 2017
Reliability and Clinical Utility of the CARDS Classification for Degenerative SpondylolisthesisGarret L Sobol, Alan Hilibrand, Ashley Davis, et al.Frontiers in Pharmacology|September 27, 2019
Considerations for an <i>In Vitro</i>, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Using Human iPSC-CardiomyocytesAlexandre J S Ribeiro, Brian D Guth, Michael Engwall, et al.Frontiers in Pharmacology|August 27, 2019
Considerations for an <i>In Vitro</i>, Cell-Based Testing Platform for Detection of Adverse Drug-Induced Inotropic Effects in Early Drug Development. Part 1: General Considerations for Development of Novel Testing PlatformsBrian D Guth, Michael Engwall, Sandy Eldridge, et al.Journal of Pharmacological and Toxicological Methods|April 7, 2015
The evaluation of drug-induced changes in cardiac inotropy in dogs: Results from a HESI-sponsored consortiumBrian D Guth, Alan Y Chiang, Jennifer Doyle, et al.Pageof 3